The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Randomised Controlled Trial Of Early Intervention To Improve Sexual And Couple Functioning After Prostate Cancer
Funder
National Health and Medical Research Council
Funding Amount
$405,000.00
Summary
Treatment for localised prostate cancer has a long term negative impact on the sexuality, quality of life, and relationship quality of Australian men and their intimate partners. This study will trial a remote access couples based sexuality intervention for this patient and carer group that has potential for broader translation into community and acute health care settings. This approach will also have broader application for chronic disease self management for other health conditions.
Supportive Care In The Digital Age: Harnessing New Technologies To Improve Adjustment To Cancer
Funder
National Health and Medical Research Council
Funding Amount
$320,003.00
Summary
Cancer survivors consider talking to someone who has been through a similar experience to be an important part of ideal cancer care. With everday use of the internet increasing, this study will test if an online one-to-one peer support program leads to benefits for haematological cancer survivors. If effective, it would improve access to peer support services among survivors in rural and remote regions, and could be adapted to other cancer types and health conditions.
Randomised Controlled Trial Of Early Intervention To Improve Sexual And Couple Functioning After Prostate Cancer
Funder
National Health and Medical Research Council
Funding Amount
$601,330.00
Summary
Treatment for localised prostate cancer has a long term negative impact on the sexuality and quality of life of Australian men and their intimate partners. This study will trial a remote access couples based sexuality intervention for this patient and carer group that has potential for broader translation.
Predicting And Promoting Improved Long Term Adjustment For Men With Localised Prostate Cancer: ProsCan
Funder
National Health and Medical Research Council
Funding Amount
$307,407.00
Summary
In the western world prostate cancer is the most common male cancer and the second most common cause of cancer death. Currently, the most contentious public health issue regarding prostate cancer is uncertainty about the benefits of diagnosing and treating prostate cancer at a localised stage. Prostate cancer is heterogeneous and the risk of morbidity and mortality from localised disease is difficult to quantify owing to the cancer's relatively slow growth rate. Thus, after the diagnosis of loca ....In the western world prostate cancer is the most common male cancer and the second most common cause of cancer death. Currently, the most contentious public health issue regarding prostate cancer is uncertainty about the benefits of diagnosing and treating prostate cancer at a localised stage. Prostate cancer is heterogeneous and the risk of morbidity and mortality from localised disease is difficult to quantify owing to the cancer's relatively slow growth rate. Thus, after the diagnosis of localised prostate cancer it is recommended that all men be advised of three possible treatment options at a minimum: watchful waiting, radiation therapy, or radical prostatectomy. Most men prefer active involvement in the treatment decision, however many find this difficult due to uncertainty about the likely survival gain; significant treatment side effects and ambiguous risk probabilities for these effects. While prostate cancer is common, mortality is low with most men surviving 10 years. This means quality of life after prostate cancer is a critical issue. Survivorship concerns for this patient group include fears about cancer recurrence; managing physical effects of treatments; and social effects such as disruption to daily living. Men seek help less for psychological difficulties than do women. Accessible and well targeted support services for men are critical. This project aims to identify men who after the diagnosis of localised prostate cancer are at risk of poorer psychosocial adjustment over the long term and to assess the effectiveness of a psychosocial and decision support intervention in improving their long term outcomes. Identification of predictors of men's adjustment over time and of effective ways to promote optimal long term outcomes are important research questions that are as yet unanswered. The present research will be the first of its kind internationally to address these questions.Read moreRead less